Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegileridine vs sufentanil for postoperative analgesia in day-case laparoscopic cholecystectomy
ChiCTR2500111661Phase 4Not yet recruiting
- Sponsor
- The Third People's Hospital of Yibin
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tegileridine in Cholecystolithiasis (2 arms), sponsored by The Third People's Hospital of Yibin. Primary endpoint: Numerical pain score (NRS) during mobilization on postoperative day 1. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
tegileridine
03
Conditions
Cholecystolithiasis
Beyond the preview
Go deeper on ChiCTR2500111661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500111661.